Meanwhile, the blood routine, routine urine, feces routine, electrocardiogram (ECG), liver function, renal function, as safety indexes, were monitored too.
以血、尿、便常规,心、肝、肾功能及不良反应为安全性指标观察。
There were no significant changes in blood routine, routine urine examination, blood sugar, blood lipid, liver function, renal function and ECG of two groups after treatment(P>0.05).
两组治疗前后血尿常规、血糖、血脂、肝功、肾功、心电图均无明显改变(P>0.05)。
At the same time detecting and recording routine, urine routine, blood glucose, liver function and renal function, ECG and adverse events before and after treatment.
同时检测和记录治疗前后血常规、尿常规、血糖、肝肾功能、心电图和不良事件。
应用推荐